These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 18780575)
1. [Therapy of acute promyelocytic leukemia in Czechia: results and analysis of prognostic factors]. Schwarz J; Korístek Z; Starý J; Zák P; Kozák T; Marková J; Michalová K; Dvoráková D; Mayer J; Cetkovský P Vnitr Lek; 2008; 54(7-8):757-70. PubMed ID: 18780575 [TBL] [Abstract][Full Text] [Related]
2. A survival study and prognostic factors analysis on acute promyelocytic leukemia at a single center. Xin L; Wan-jun S; Zeng-jun L; Yao-zhong Z; Yun-tao L; Yan L; Chang-chun W; Qiao-chuan L; Ren-chi Y; Ming-zhe H; Jian-xiang W; Lu-gui Q Leuk Res; 2007 Jun; 31(6):765-71. PubMed ID: 17007927 [TBL] [Abstract][Full Text] [Related]
3. Long-term survival and prognostic study in acute promyelocytic leukemia treated with all-trans-retinoic acid, chemotherapy, and As2O3: an experience of 120 patients at a single institution. Hu J; Shen ZX; Sun GL; Chen SJ; Wang ZY; Chen Z Int J Hematol; 1999 Dec; 70(4):248-60. PubMed ID: 10643151 [TBL] [Abstract][Full Text] [Related]
4. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience]. Rolovitsh Z; Cholovitsh M; Elezovitsh I; Vidovitsh A; Radoshevitsh-Radojkovitsh N; Boshkovitsh D; Novak A; Basara N Srp Arh Celok Lek; 1995; 123(11-12):279-85. PubMed ID: 16296239 [TBL] [Abstract][Full Text] [Related]
5. [Long-term follow-up of treatment outcome and prognosis on 46 children with acute promyelocytic leukemia]. Xu XJ; Shi SW; Tang YM; Song H; Yang SL; Wei J; Xu WQ; Pan BH; Chen YH; Zhao FY; Shen HQ; Qian BQ; Zhang LY; Ning BT Zhongguo Dang Dai Er Ke Za Zhi; 2007 Feb; 9(1):28-33. PubMed ID: 17306073 [TBL] [Abstract][Full Text] [Related]
6. [Prevalence and clinical significance of FLT3 mutations in acute promyelocytic leukemia]. Xue MX; Qiu HY; Feng YF; Zhu ZL; Chang WR; Liang JY; Chen SN; Cen JN; Xue YQ; Liu YJ; Sun AN; Wu DP Zhonghua Xue Ye Xue Za Zhi; 2008 Nov; 29(11):757-61. PubMed ID: 19176014 [TBL] [Abstract][Full Text] [Related]
7. Different clinical importance of FLT3 internal tandem duplications in AML according to FAB classification: possible existence of distinct leukemogenesis involving monocyte differentiation pathway. Koh Y; Park J; Ahn KS; Kim I; Bang SM; Lee JH; Yoon SS; Soon Lee D; Yiul Lee Y; Park S; Kim BK Ann Hematol; 2009 Nov; 88(11):1089-97. PubMed ID: 19296110 [TBL] [Abstract][Full Text] [Related]
8. Treatment with all-trans retinoic acid and anthracycline monochemotherapy for children with acute promyelocytic leukemia: a multicenter study by the PETHEMA Group. Ortega JJ; Madero L; Martín G; Verdeguer A; García P; Parody R; Fuster J; Molines A; Novo A; Debén G; Rodríguez A; Conde E; de la Serna J; Allegue MJ; Capote FJ; González JD; Bolufer P; González M; Sanz MA; J Clin Oncol; 2005 Oct; 23(30):7632-40. PubMed ID: 16234524 [TBL] [Abstract][Full Text] [Related]
9. Comparison of anthracycline-based combination chemotherapy with or without all-trans retinoic acid in acute promyelocytic leukemia. Raza S; Ullah K; Ahmed P; Khan B J Coll Physicians Surg Pak; 2008 Sep; 18(9):546-50. PubMed ID: 18803891 [TBL] [Abstract][Full Text] [Related]
10. Improved outcome of acute promyelocytic leukemia with high WBC counts over the last 15 years: the European APL Group experience. Kelaidi C; Chevret S; De Botton S; Raffoux E; Guerci A; Thomas X; Pigneux A; Lamy T; Rigal-Huguet F; Meyer-Monard S; Chevallier P; Maloisel F; Deconinck E; Ferrant A; Fegueux N; Ifrah N; Sanz M; Dombret H; Fenaux P; Adès L J Clin Oncol; 2009 Jun; 27(16):2668-76. PubMed ID: 19414681 [TBL] [Abstract][Full Text] [Related]
11. Long-term survey of outcome in acute promyelocytic leukemia: a single center experience in 340 patients. Liu YJ; Wu DP; Liang JY; Qiu HY; Jin ZM; Tang XW; Fu CC; Ma X Med Oncol; 2011 Dec; 28 Suppl 1():S513-21. PubMed ID: 21069477 [TBL] [Abstract][Full Text] [Related]
12. All-trans retinoic acid/As2O3 combination yields a high quality remission and survival in newly diagnosed acute promyelocytic leukemia. Shen ZX; Shi ZZ; Fang J; Gu BW; Li JM; Zhu YM; Shi JY; Zheng PZ; Yan H; Liu YF; Chen Y; Shen Y; Wu W; Tang W; Waxman S; De Thé H; Wang ZY; Chen SJ; Chen Z Proc Natl Acad Sci U S A; 2004 Apr; 101(15):5328-35. PubMed ID: 15044693 [TBL] [Abstract][Full Text] [Related]
13. Clinico-biological features and outcome of acute promyelocytic leukemia patients with persistent polymerase chain reaction-detectable disease after the AIDA front-line induction and consolidation therapy. Breccia M; Diverio D; Noguera NI; Visani G; Santoro A; Locatelli F; Damiani D; Marmont F; Vignetti M; Petti MC; Lo Coco F Haematologica; 2004 Jan; 89(1):29-33. PubMed ID: 14754603 [TBL] [Abstract][Full Text] [Related]
14. Flt3 internal tandem duplication and P-glycoprotein functionality in 171 patients with acute myeloid leukemia. Marzac C; Teyssandier I; Calendini O; Perrot JY; Faussat AM; Tang R; Casadevall N; Marie JP; Legrand O Clin Cancer Res; 2006 Dec; 12(23):7018-24. PubMed ID: 17145823 [TBL] [Abstract][Full Text] [Related]
15. Internal tandem duplication of the FLT3 gene confers poor overall survival in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based chemotherapy: an International Consortium on Acute Promyelocytic Leukemia study. Lucena-Araujo AR; Kim HT; Jacomo RH; Melo RA; Bittencourt R; Pasquini R; Pagnano K; Fagundes EM; Chauffaille Mde L; Chiattone CS; Lima AS; Ruiz-Argüelles G; Undurraga MS; Martinez L; Kwaan HC; Gallagher R; Niemeyer CM; Schrier SL; Tallman MS; Grimwade D; Ganser A; Berliner N; Ribeiro RC; Lo-Coco F; Löwenberg B; Sanz MA; Rego EM Ann Hematol; 2014 Dec; 93(12):2001-10. PubMed ID: 24981688 [TBL] [Abstract][Full Text] [Related]
16. Is cytarabine useful in the treatment of acute promyelocytic leukemia? Results of a randomized trial from the European Acute Promyelocytic Leukemia Group. Adès L; Chevret S; Raffoux E; de Botton S; Guerci A; Pigneux A; Stoppa AM; Lamy T; Rigal-Huguet F; Vekhoff A; Meyer-Monard S; Maloisel F; Deconinck E; Ferrant A; Thomas X; Fegueux N; Chomienne C; Dombret H; Degos L; Fenaux P; J Clin Oncol; 2006 Dec; 24(36):5703-10. PubMed ID: 17116939 [TBL] [Abstract][Full Text] [Related]
17. Use of all-trans retinoic acid in combination with arsenic trioxide for remission induction in patients with newly diagnosed acute promyelocytic leukemia and for consolidation/maintenance in CR patients. Dai CW; Zhang GS; Shen JK; Zheng WL; Pei MF; Xu YX; Cao YX; Yi Y; Yang JJ; Peng HL; Zhong HY; Li RJ Acta Haematol; 2009; 121(1):1-8. PubMed ID: 19246888 [TBL] [Abstract][Full Text] [Related]
18. Additional cytogenetic changes do not influence the outcome of patients with newly diagnosed acute promyelocytic leukemia treated with an ATRA plus anthracyclin based protocol. A report of the Spanish group PETHEMA. Hernández JM; Martín G; Gutiérrez NC; Cervera J; Ferro MT; Calasanz MJ; Martínez-Climent JA; Luño E; Tormo M; Rayón C; Díaz-Mediavilla J; González M; González-San Miguel JD; Pérez-Equiza K; Rivas C; Esteve J; Alvarez Mdel C; Odriozola J; Ribera JM; Sanz MA; Haematologica; 2001 Aug; 86(8):807-13. PubMed ID: 11522536 [TBL] [Abstract][Full Text] [Related]